Small-cap shares can provide massive progress alternatives for traders keen to tackle some danger. SBI Securities has recognized 5 small-cap shares with sturdy potential to ship as much as 38 % returns. These firms, typically lesser-known however with strong fundamentals, are poised for progress in 2025, making them price contemplating in your funding portfolio.
Listed below are a couple of small-cap shares beneficial by SBI Securities with a excessive progress potential of as much as 38 %:
With a market capitalization of Rs. 4,211.81 crore, the shares of Lumax Auto Applied sciences Restricted closed at Rs. 617.95 per fairness share, down practically 0.52 % from its earlier day’s shut value of Rs. 621.15.
SBI Securities, a outstanding brokerage agency, has beneficial a “Purchase” name on Lumax Auto Applied sciences Restricted with a goal value of Rs. 854 per share, indicating an upside potential of 38.20 %.
Lumax Auto Applied sciences Restricted was established in 1981 and is a Gurugram-based firm beneath the D.Ok. Jain Group. It manufactures automotive parts like gear shifters, lighting, and consumption methods for 2, three, and four-wheelers. With 26 amenities throughout India, it serves OEMs and the aftermarket, holding a number one place in gear shifters.
With a market capitalization of Rs. 14,256.69 crore, the shares of Pressure Motors Restricted closed at Rs. 10,939 per fairness share, down practically 1.40 % from its earlier day’s shut value of Rs. 11,094.
SBI Securities, a outstanding brokerage agency, has beneficial a “Purchase” name on Pressure Motors Restricted with a goal value of Rs. 13,200 per share, indicating an upside potential of 20.67 %.
Pressure Motors Restricted was established in 1958 and is a Pune-based firm. It manufactures industrial automobiles, tractors, and automotive parts, specializing in utility automobiles like vans and buses. The corporate additionally produces engines and axles, serving each home and worldwide markets with a robust presence in India.
With a market capitalization of Rs. 21,627.07 crore, the shares of Amber Enterprises India Restricted closed at Rs. 6,390.60 per fairness share, up practically 0.69 % from its earlier day’s shut value of Rs. 6,346.65.
SBI Securities, a outstanding brokerage agency, has beneficial a “Purchase” name on Amber Enterprises India Restricted with a goal value of Rs. 7,160 per share, indicating an upside potential of 12.04 %.
Amber Enterprises India Restricted was established in 1990 and is a Gurugram-based firm. It’s a main producer of room air conditioners and parts, serving as an OEM/ODM for main manufacturers. The corporate additionally produces electronics like PCBs and HVAC options, with 23 manufacturing amenities throughout India.
With a market capitalization of Rs. 9,101.61 crore, the shares of Privi Speciality Chemical substances Restricted closed at Rs. 2,330 per fairness share, down practically 0.58 % from its earlier day’s shut value of Rs. 2,343.55.
SBI Securities, a outstanding brokerage agency, has beneficial a “Purchase” name on Privi Speciality Chemical substances Restricted with a goal value of Rs. 2,662 per share, indicating an upside potential of 14.25 %.
Privi Speciality Chemical substances Restricted was established in 1985 and is a Mumbai-based firm. It’s India’s main producer, provider, and exporter of aroma and perfume chemical substances, serving international perfume and taste industries. With amenities in Maharashtra and Gujarat, Privi exports to over 50 international locations, producing over 75 merchandise.
With a market capitalization of Rs. 5,600.80 crore, the shares of Supriya Lifescience Restricted closed at Rs. 695.90 per fairness share, down practically 1.90 % from its earlier day’s closing value of Rs. 709.35.
SBI Securities, a outstanding brokerage agency, has beneficial a “Purchase” name on Supriya Lifescience Restricted with a goal value of Rs. 810 per share, indicating an upside potential of 16.40 %.
Supriya Lifescience Restricted was established in 1987 and is a Mumbai-based pharmaceutical firm. It manufactures lively pharmaceutical components (APIs) for medicines, specializing in areas like anti-histamines, nutritional vitamins, and anesthetics. The corporate exports to over 86 international locations and has amenities in Maharashtra accredited by the USFDA and EUGMP.
Written By – Nikhil Naik
Disclaimer
The views and funding ideas expressed by funding specialists/broking homes/ranking companies on tradebrains.in are their very own, and never that of the web site or its administration. Investing in equities poses a danger of economic losses. Buyers should subsequently train due warning whereas investing or buying and selling in shares. Dailyraven Applied sciences or the writer are usually not answerable for any losses triggered because of the choice primarily based on this text. Please seek the advice of your funding advisor earlier than investing.
